AAIC 2025 Abstract
Spectris TM combined audiovisual sensory stimulation elicits stronger EEG brain response than auditory or visual stimulation alone
Trial in peopleInterventions
Abstract
Background: The recent Overture (NCT03556280) clinical trial demonstrated reduced decline in cognitive and functional abilities and reduced brain atrophy in participants with mild to moderate Alzheimer's disease (AD) after 6‐months of daily, at‐home treatment with Cognito Therapeutics’ Spectris™ investigational medical
